COLD SPRING HARBOR LABORATORY           

 

              Quantitative Imaging Cytometry   

 

 
Tuesday, February 20, 2007

 

Woodbury Auditorium / Genome Research Center

Cold Spring Harbor Laboratory – Woodbury Campus

500 Sunnyside Boulevard

Woodbury, NY  11797

 
 

 

 

MORNING SESSION:  INTRODUCTION TO THE TECHNOLOGY AND ITS APPLICATION TO CELL CYCLE ANALYSIS AND APOPTOSIS

 

Welcome - William P. Tansey, Lita Annenberg Hazen Professor of Biological Sciences, Director of Graduate Studies, Cold Spring Harbor Laboratory

  Keynote Address:  “Cellular Life as a Biochemical Finite State Machine: Implications fo Cell Based Assays” - James Jacobberger, PhD, Professor of Oncology, Associate Director for Shared Resources and Director, Cytometry Core Case Comprehensive Cancer Center, Cleveland, OH
 

“Activation of ATM and phosphorylation of H2AX reporters of DNA damage - Zbigniew Darzynkiewicz. MD, PhD, Brander Cancer Research Institute, New York Medical College, Valhalla, NY

 

“An introduction to Laser Scanning Cytometry:  Individuals Cells and Whole Tissues”  (LSC technology and applications update, with focus on apoptosis and tissue analysis)
William Telford, PhD, Core Flow Cytometry, NIH/NCI, Bethesda, MD

 

"Quantitative analysis of JNK signaling in a mouse model of Parkinsons disease by Laser Scanning Cytometry" - Deirdre Buckley, PhD, Tonks Lab, Cold Spring Harbor Laboratory

   
 

AFTERNOON SESSION:  TISSUE CYTOMETRY AND PATHOLOGY

 

Keynote Address:  “Pharmacodynamic monitoring of molecular cancer therapeutics at the preclinical and early clinical stages of development” - David W Hedley, MD, Dept. of Medical Oncology and Hematology, Division of Experimental Therapeutics, Princess Margaret Hospital/Ontario Cancer Institute, University of Toronto

 

“An automated method to monitor skin mast cells by Laser Scanning Cytometry” - Gloria Juan, Sr. Scientist, Clinical Immunology, Amgen

 

“LSC analysis of tissue microarrays:  Application to subcellular localization of p27 and prostate cancer recurrence” - Peter Gann, MD, ScD, Department of Pathology, College of Medicine, University of Illinois at Chicago

 

“Quantitative Imaging Cytometry:  Technology to support the new role of pathology in the era of specific targeted therapies”- William Geddie, MD, Department of Laboratory Medicine and Pathobiology, University of Toronto

 

"Quantification of Three Color Quantum Dot Labeled Pancreatic Hormones using the Laser Scanning Cytometer" - David Krull, Senior Scientist, Molecular and Ultrastructural Pathology, GlaxoSmithKline Safety Assessment, Research Triangle Park, NC